πŸ›οΈ Verified NIH Record β€’ Updated 2024-11-12

Evaluation of the Safety and Efficacy of TLD in Patients with COPD (NCT03639051)

A Multicenter, Randomized, Sham-controlled Study to Evaluate Safety and Efficacy After Treatment with the Nuvairaβ„’ Lung Denervation System in Patients with Chronic Obstructive Pulmonary Disease (COPD)

πŸ”΅ Active, Not Recruiting Observational / Diagnostic βš™οΈ Medical Device Protocol Sponsor: Nuvaira, Inc.

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to confirm the safety and efficacy of the Nuvaira Lung Denervation System (Nuvaira System) in the treatment of COPD.

Who can join: Review the eligibility criteria below.

Location: University of Alabama at Birmingham (UAB) Lung Health Center β€” Birmingham, Alabama

Age range: 40 Years

πŸ§ͺ Interventions in This Study

πŸ“‹ "Do I Qualify?" β€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria β†—

πŸ“ All Participating Trial Locations (33 Sites)

Showing the first 25 of 33 sites.

  • University of Alabama at Birmingham (UAB) Lung Health Center β€” Birmingham, Alabama
  • HonorHealth β€” Phoenix, Arizona
  • UC Davis β€” Sacramento, California
  • Harbor UCLA β€” Torrance, California
  • Ascension St. Vincent's β€” Jacksonville, Florida
  • University of Chicago β€” Chicago, Illinois
  • Suburban Lung Associates β€” Elk Grove Village, Illinois
  • University of Louisville β€” Louisville, Kentucky
  • Lahey Hospital & Medical Center β€” Burlington, Massachusetts
  • University of Michigan β€” Ann Arbor, Michigan
  • Spectrum Health Medical Group β€” Grand Rapids, Michigan
  • Washington University β€” St Louis, Missouri
  • Duke University β€” Durham, North Carolina
  • First Health of the Carolinas β€” Pinehurst, North Carolina
  • Ohio State University Wexner Medical Center β€” Columbus, Ohio
  • Temple Lung Center β€” Philadelphia, Pennsylvania
  • University of Pittsburgh Medical Center (UPMC) β€” Pittsburgh, Pennsylvania
  • Medical University of South Carolina (MUSC) β€” Charleston, South Carolina
  • St. Davids HealthCare β€” Georgetown, Texas
  • Houston Methodist Hospital β€” Houston, Texas
  • Krankenhaus Nord - Klinik Floridsdorf β€” Vienna,
  • CHU de Grenoble β€” Grenoble, Cedex 9
  • Hopital Larrey β€” Toulouse, Cedex 9
  • Hopital de la Cavale Blanche β€” Brest,
  • Arnaud de Villeneuve Hospital β€” Montpellier,

πŸ’° Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All COPD clinical trials

πŸ’‘ How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
πŸ›οΈ View Official NIH Record β†—